HealthDay: Immunotherapy drug did not increase adverse surgery events
September 15, 2022
HealthDay highlighted recent University of Cincinnati research that found administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.